Ignite Creation Date:
2024-07-17 @ 11:02 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06484816
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-26
Brief Title:
TGRX-1942 Chinese Phase I for Advanced Solid Tumor andor RelapsedRefractory Hematologic Malignancies
Sponsor:
Shenzhen TargetRx Inc
Organization:
Shenzhen TargetRx Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-26
First Submit QC Date:
None
Study First Post Date:
2024-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-26
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL